Advocacy intelligence hub — real-time data for patient organizations
Qalsody: FDA approved
treatment of amyotrophic lateral sclerosis (ALS) in adults who have a mutation in the superoxide dismutase 1 (SOD1) gene
Rilutek: FDA approved
Treatment of patients with amyotrophic lateral sclerosis. Riluzole extends survival and/or time to tracheostomy.
Metrodin: FDA approved
For induction of ovulation in patients with polycystic ovarian disease who have an elevated LH/FSH ratio and who have failed to respond to adequate clomiphene citrate therapy.
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Copay cards
Copay Assistance2
Rilutek
Rhone-Poulenc Rorer Pharmaceuticals, Inc.
Metrodin
EMD Serono, Inc.
Patient Assistance Programs1
Qalsody
Biogen Inc.
Browse all Inclusion body myopathy with Paget disease of bone and frontotemporal dementia news →